Evidence
What the drug label describes
The Zepbound label describes tirzepatide acting on both the GIP and GLP-1 signals.
DailyMed · US National Library of Medicine
Read the Zepbound drug labelStart with the ingredient, then check the product.
Tirzepatide is an ingredient name.
Myth to check
The word peptide puts every product in the same box.
Rethink that tirzepatide assumption
Calling something a peptide tells you about the pieces it contains. The word alone says nothing about the medical checks that a product has passed.
Picture small pieces joined in a short row: that is a peptide. Proteins are built from the same kinds of pieces. Insulin is a peptide too.
The useful question is about the exact product, rather than the word peptide on its own.
Tirzepatide copies two of the body’s messages about appetite and blood sugar. They are called GIP and GLP-1.
Tirzepatide has been tested in people.
Studies in animals help explain how copying GIP might affect how much food is eaten. They do not prove how much GIP adds to the effect of copying GLP-1 in people.
The FDA, the US medicine regulator, reviews specific drug products for specific uses.
As of 26 September 2026, tirzepatide (Mounjaro, Zepbound) had FDA-approved injection products.
Mounjaro and Zepbound are names of approved medicines. An offer called “tirzepatide” could be for a different preparation. The name alone does not prove it passed the same checks.
Ask for the medicine’s full name and what health problem it would treat. Ask whether it is an approved brand or made to order.
Compounding means preparing medicine to meet a particular need. A pharmacist or doctor prepares it instead of supplying a ready-made medicine.
Evidence
The Zepbound label describes tirzepatide acting on both the GIP and GLP-1 signals.
DailyMed · US National Library of Medicine
Read the Zepbound drug labelEvidence
FDA approval is not a label that applies to everything called a peptide.
Food and Drug Administration (FDA), US
See how the FDA explains approval